Tabula Rasa HealthCare Announces VigiLanz Precision Dosing Powered by DoseMeRx
In this article:
Tabula Rasa HealthCare® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, has partnered with VigiLanz®, the leading provider in clinical surveillance, to integrate with DoseMeRx™, TRHC’s precision dosing solution. The integration of DoseMeRx within VigiLanz’s award-winning software platform will provide hospital customers with instant access to personalized dosing for vancomycin and other antimicrobials, optimizing pharmacy workflow and improving patient safety.
VigiLanz is the 2020 Category Leader for Antimicrobial Stewardship, Infection Control and Monitoring, and Pharmacy Surveillance by KLAS Research. This is the third consecutive year, VigiLanz ranked top for Pharmacy Surveillance and second year in a row ranking top for Antimicrobial Stewardship and Infection Control and Monitoring.
“Our partnership with Tabula Rasa HealthCare and DoseMeRx enables providers to easily optimize the dosing of vancomycin and other high-risk antimicrobials,” said VigiLanz Chairman and CEO David Goldsteen, MD. “This is especially critical with the release of the new vancomycin dosing guidelines, which are indicative of a growing trend toward increased medication safety. DoseMeRx brings immense value to pharmacists. Together, we’re excited to bring precision dosing to our customers.”
The VigiLanz platform provides leading pharmacy surveillance and antimicrobial stewardship solutions for hospitals to generate real-time alerts that help clinicians make appropriate drug therapy decisions. Adding DoseMeRx will enable VigiLanz customers to easily implement the new national dosing guidelines for vancomycin – one of the most commonly used antibiotics in hospitals today.
“This partnership means convenient access for VigiLanz customers to the precision dosing capabilities of DoseMeRx to optimize the use of vancomycin in the acute care setting,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “Our goal is to expand and scale the use of DoseMeRx, along with other TRHC platforms, to more pharmacists who will use it to optimize medication safety. This partnership does just that.
According to TRHC Executive Vice President for DoseMe/Hospitals Business Unit, Charles Cornish, the opportunity to integrate DoseMeRx with the VigiLanz solution is of benefit to customers looking for a closed-loop solution to clinical surveillance and dose optimization. “VigiLanz and TRHC share the common goal of building easy-to-use clinical decision software with the ability to improve workflows and support pharmacists,” said Cornish.
Founded in 2001, VigiLanz is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care. To learn more about VigiLanz Precision Dosing, powered by DoseMeRx, visit their website.
Explore our integration now available inside VigLanz →